Degradation of fibrin-β amyloid co-aggregate: A novel function attributed to ubiquitin

Biochimica Et Biophysica Acta. Molecular Cell Research
Payel BhattacharjeeDebasish Bhattacharyya

Abstract

Human placental extract contains numerous bioactive components that are effective wound healing, antimicrobial and anti-inflammatory agents. During our investigation on the therapeutic potency of human placental extract, we have purified ubiquitin-like molecules that showed strong fibrino(geno)lytic activity. Further investigation confirmed similar potency of ubiquitin purified from adult human erythrocyte. Additionally, ubiquitin efficiently degraded disordered amyloid β 42 peptide (Aβ42) aggregate and fibrin-Aβ42 co-aggregate in vitro and reduced co-aggregate induced cytotoxicity in SH-SY5Y human neuroblastoma cells as compared to plasmin. Ubiquitin also degraded abnormal co-aggregates of fibrin with other plasma proteins such as fibronectin, albumin, lysozyme, tranthyretin and α-synuclein. To elucidate the mechanism of degradation, synthetic peptides (ADG, GKT, DQQ, QRL, LIF, AGK, HLVL) derived from ubiquitin template as well as synthetic ubiquitin (8565.32 Da) were employed. Synthetic ubiquitin completely degraded preformed Aβ 42 aggregate and fibrin-Aβ42 co-aggregate, whereas, the smaller synthetic peptides showed varying degrees of degradation. These observations attribute a novel function of ubiquitin that may be used fo...Continue Reading

References

May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G PerryV Chau
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·V A FriedK Weiner
Mar 1, 1987·Stroke; a Journal of Cerebral Circulation·H V Vinters
Apr 1, 1996·Brain Pathology·M M Reilly, H Staunton
Sep 29, 1998·Analytical Biochemistry·S H KimW Y Lee
Oct 1, 1952·Archives of Biochemistry and Biophysics·T ASTRUP, S MULLERTZ
Mar 17, 2004·Journal of Pharmaceutical and Biomedical Analysis·Piyali Datta, Debasish Bhattacharyya
Nov 5, 2005·Stroke; a Journal of Cerebral Circulation·Marieke van OijenMonique M B Breteler
Apr 29, 2009·International Journal of Molecular Sciences·Gabor G Kovacs, Herbert Budka
Oct 14, 2009·Alzheimer's Research & Therapy·Roy O WellerRoxana O Carare
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hyung Jin AhnSidney Strickland
Feb 18, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Susan T Lord
Feb 22, 2011·Toxicon : Official Journal of the International Society on Toxinology·Gargi MaityDebasish Bhattacharyya
Apr 27, 2011·Journal of Cellular Physiology·Debashree DeDebasish Bhattacharyya
Dec 1, 2012·Stem Cells Translational Medicine·Igor NazarovVladimir B Serikov
Apr 5, 2013·PloS One·Debashree DeDebasish Bhattacharyya
May 9, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Karin HultmanErin H Norris
Aug 30, 2013·The Journal of Biological Chemistry·Payel Bhattacharjee, Debasish Bhattacharyya
Jul 1, 2012·European Neurological Review·Octavio M Pontes-NetoSteven M Greenberg
May 14, 2014·The Journal of Experimental Medicine·Hyung Jin AhnSidney Strickland

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.